T cell developmental arrest in former premature infants increases risk of respiratory morbidity later in infancy

Area of Science:

• Immunology
• Neonatal Medicine
• Developmental Biology

Background:

• Preterm birth (PT) is linked to increased postviral respiratory morbidity, suggesting impaired T cell maturation.
• Understanding fetal T cell development and its disruption in preterm infants is crucial for improving outcomes.
• Limited data exists on how ex utero development affects T cell maturation and subsequent infant health.

Purpose of the Study:

• To investigate normal human fetal T cell maturation during gestation.
• To examine how premature birth impacts T cell development.
• To determine if T cell development influences respiratory outcomes in infants.

Main Methods:

• Longitudinal cohort study of 157 infants (23-42 weeks gestation).
• Analysis of T cell populations at birth and during postnatal development.
• Correlation of T cell profiles with respiratory outcomes at 1 year of age.

Main Results:

• Identified gestational age-dependent differences in T cells at birth.
• Observed postnatal T cell development patterns predicting respiratory outcomes.
• Found naive CD4+ T cells shift from CD31-TNF-α+ to CD31+IL-8+ dominance by term gestation.
• Preterm infants with low CD31+IL8+CD4+ T cells showed >3.5-fold increased risk of respiratory complications post-NICU discharge.

Conclusions:

• This study identifies a normal pattern of functional T cell development in late gestation.
• Abnormal T cell development is associated with adverse health outcomes in infants.
• Findings highlight the importance of T cell maturation for respiratory health in preterm infants.